COX Inhibition and Biomarkers of Response During Neoadjuvant Chemoendocrine Therapy for Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Stage I-III Breast Cancer

IRB/UVA Tracking #
21822
Contact
Olena Glushakova
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Patrick M Dillon
Status
OPEN TO ACCRUAL
Ages
Adult